PLSH (Panacea Life Sciences Holdings) Net Margin %: -368.00% (As of Sep. 2025)


What is Panacea Life Sciences Holdings Net Margin %?

Panacea Life Sciences Holdings PLSH +3.64% Net Margin % is -368.00% as of Sep. 2025. The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks better than 98.74% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Panacea Life Sciences Holdings's Net Income for the three months ended in Sep. 2025 was $-0.18 Mil. Panacea Life Sciences Holdings's Revenue for the three months ended in Sep. 2025 was $0.05 Mil. Therefore, Panacea Life Sciences Holdings's net margin for the quarter that ended in Sep. 2025 was -368.00%.

The historical rank and industry rank for Panacea Life Sciences Holdings's Net Margin % or its related term are showing as below:

PLSH' s Net Margin % Range Over the Past 10 Years
Min: -561.95   Med: -284.1   Max: 91.29
Current: 91.29

PLSH's Net Margin % is ranked better than
98.74% of 956 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs PLSH: 91.29

Panacea Life Sciences Holdings  (OTCPK:PLSH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Panacea Life Sciences Holdings Net Margin % Related Terms

Panacea Life Sciences Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Net Margin % Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Margin %
-58.02 -232.14 -561.95 -336.06

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -124.53 -118.97 -0.50 452.56 -368.00

PLSH vs NPHC, OWPC, CBDY: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Life Sciences Holdings Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Net Margin % falls into.


Panacea Life Sciences Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Panacea Life Sciences Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-8.015/2.385
=-336.06 %

Panacea Life Sciences Holdings's Net Margin for the quarter that ended in Sep. 2025 is calculated as

Net Margin=Net Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.184/0.05
=-368.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -368.00% mean?
Panacea Life Sciences Holdings (PLSH) has a Net Margin % of -368.00% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #12 out of 956 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is Panacea Life Sciences Holdings' Net Margin % too high?
Panacea Life Sciences Holdings' current Net Margin % is -368.00%. Based on the distribution chart, Panacea Life Sciences Holdings ranks #12 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Panacea Life Sciences Holdings' Net Margin % compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #12 out of 956 companies for Net Margin %. This places Panacea Life Sciences Holdings in the top 1% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current Net Margin % is -368.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Net Margin % of -368.00%. The current Net Margin % is -368.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Net Margin % is -368.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.